• 1
    Hagerman R. Clinical and diagnostic aspects of fragile X syndrome. In: WellsRD, WarrenST, eds. Genetic instabilities and hereditary neurological diseases. New York : Academic Press, 1998:1523.
  • 2
    Turner G, Webb T, Wake S, Robinson H. The prevalence of the fragile X syndrome. Am J Med Genet 1996;64:1967.
  • 3
    Kooij RF, Oostra BA, Willems PJ. The fragile X syndrome and other fragile site disorders. In: OostraBA, ed. Trinucleotide diseases and instability. Heidelberg : Springer, 1998:16.
  • 4
    Fu YH, Kuhl DP, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:104758.
  • 5
    Pieretti M, Zhang FP, Fu YH, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991;66:81722.
  • 6
    Verheij C, Bakker CE, de Graaff E, et al. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 1993;363:7224.
  • 7
    Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 1993;4:33540.
  • 8
    Deelen W, Bakker C, Halley D, Oostra BA. Conservation of CGG region in FMR1 gene in mammals. Am J Med Genet 1994;51:5136.
  • 9
    Ashley CT, Sutcliffe JS, Kunst CB, et al. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat Genet 1993;4:24451.
  • 10
    Comery TA, Harris JB, Willems PJ, et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 1997;94:54014.
  • 11
    Bakker CE, Verheij C, Willemsen R, et al. Fmrl knockout mice: a model to study fragile X mental retardation. Cell 1994;78:2333.
  • 12
    Kooy RF, Dhooge R, Reyniers E, et al. Transgenic mouse model for the fragile X syndrome. Am J Med Genet 1996;64:2415.
  • 13
    Musumeci SA, Hagerman RJ, Ferri R, et al. Epilepsy, and EEG findings in males with fragile X syndrome. Epilepsia 1999;40:10929.
  • 14
    Musumeci SA, Colognola RM, Ferri R, et al. Fragile-X syndrome: a particular epileptogenic EEG pattern. Epilepsia 1988;29:417.
  • 15
    Ferri R, Musumeci SA, Elia M, Del Gracco S, Scuderi C, Bergonzi P. Bit-mapped somatosensory evoked potentials in the fragile X syndrome. Neurophysiol Clin 1994;24:41326.
  • 16
    Hall CS. Genetic differences in fatal audiogenic seizures. J Hered 1947;38:36.
  • 17
    Engstrom FL, Woodbury DM. Seizure susceptibility in DBA and C57 mice: the effects of various convulsants. Epilepsia 1988;29:38995.
  • 18
    Wang H, Burdette LJ, Frankel WN, Masukawa LM. Paroxysmal discharges in the EL mouse, a genetic model of epilepsy. Brain Res 1997;760:26671.
  • 19
    Neumann PE, Seyfried TN. Mapping of two genes that influence susceptibility to audiogenic seizures in crosses of C57BL/6J and DBA/2J mice. Behav Genet 1990;20:30723.
  • 20
    Rise ML, Frankel WN, Coffin JM, Seyfried TN. Genes for epilepsy mapped in the mouse. Science 1991;253:66973.
  • 21
    Brennan TJ, Seeley WW, Kilgard M, Schreiner CE, Tecott LH. Sound-induced seizures in serotonin 5-HT2C receptor mutant mice. Nat Genet 1997;16:38790.
  • 22
    Goelz MF, Mahler J, Harry J, et al. Neuropathologic findings associated with seizures in FVB mice. Lab Anim Sci 1998;48:347.
  • 23
    Desai HB, Donat J, Shokeir MH, Munoz DG. Amyotrophic lateral sclerosis in a patient with fragile X syndrome. Neurology 1990;40:37880.
  • 24
    Rudelli RD, Brown WT, Wisnicwski HM. Adult fragile X syndrome. Acta Neuropathol (Berl) 1985;67:28995.
  • 25
    Hinton VJ, Brown WT, Wisniewski K, Rudelli RD. Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet 1991;41:28994.
  • 26
    Holmes GL. Pathogenesis of epilepsy: the role of excitatory amino acids. Cleve Clin J Med 1995;62:2407.
  • 27
    Reiss AL, Lee J, Freund L. Neuroanatomy of fragile X syndrome: the temporal lobe. Neurology 1994;44:131724.
  • 28
    Abitbol M, Menini C, Delezoide AL, Rhyner T, Vekemans M, Mallet J. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet 1993;4:14753.
  • 29
    Eberhart DE, Malter HE, Feng Y, Warren ST. The fragile X mental retardation protein is a ribosonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 1996;5:108391.
  • 30
    Tamanin F, Bontekoe C, Bakker CE, et al. Different targets for the fragile X related proteins revealed by their distinct nuclear localizations. Hum Mol Genet 1999 (in press).
  • 31
    Siomi MC, Zhang Y, Siomi H, Dreyfuss G. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol Cell Biol 1996;16:382532.
  • 32
    Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersch SM. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 1997;17:153947.